Objective: Emergence of community-acquired infections due to multi drug resistant (MDR) common human pathogens have caused a great problem to clinicians and this directed us to search systematically for a different remedy with compounds particularly from plant origin. Methods: The antibacterial activity was evaluated using agar well diffusion assay method against some common gram positive and gram negative bacteria. Results: In vitro study with Terminalia chebula Retz. (Combretaceae) stem bark extracts, eight isolated triterpenoids and four triterpenoid derivatives were found to be effective against Bacillus subtilis, Staphylococcus aureus, Salmonella typhi, Pseudomonas aeruginosa and Escherichia coli. Conclusions: Pure compounds from T.chebula could be effectively used as antibacterial agents if it is possible to develop the molecules synthetically. At the same time crude extracts with specified active principles could also be used and/or introduced in Traditional Medicine/Complementary Alternative Medicine (TM/CAM) as antibacterial into National/International Health Systems as per the guideline of Ayurvedic formularies.
health care systems in both community and hospital settings and the present scenario demands nothing but the new generation of antibiotics desperately [6] [7] [8] . One helpful clue regarding the search for new antimicrobial compounds is the invincibility of plants against several microbial pathogens [9] [10] . Study suggests that an enormous array of secondary metabolites is produced by the plants and interestingly a significant part of these phytochemicals helps to prevent themselves from pathogens of microbial origin [11] . Terminalia chebula Retz. [12] belonging to the family Combretaceae is commonly known as "Haritaki" in both Bengali and Sanskrit. It is called the "King of Medicine" and is always listed first in Ayurvedic Materia Medica for its extraordinary powers of healing with a wide spectrum of biological activity. It has been extensively used in both Ayurvedic and Unani medicines and has become a cynosure of modern medicine. The fruit of this plant is reported to have local application to chronic ulcers and wounds and gargle in stomatitis as well. Finely powered fruit is used as a dentifrice and considered to be useful in carious teeth, bleeding and ulcerations of the gum. It is also reported to have antioxidant and free radical scavenging activities [13] [14] . Different extracts of the fruits of T.chebula were previously found to have antibacterial activity. However, in this study, the in vitro effectiveness of stem-berk extracts of T.chebula as well as eight isolated triterpenoids and four related derivatives against some common gram-positive and gram-negative bacteria which are generally pathogenic to human beings have been shown.
Materials and Methods

Collection of Plant Material
The stem bark of the plant, T chebula was collected from Bankura district of West Bengal in the middle of Oct'2011 and was authenticated by the Taxonomist, Department of Taxonomy, Shyamadas Baidya Shastrapith, Kolkata, and West Bengal, India. A voucher specimen was deposited in the department of Clinical and Experimental Pharmacology, School of Tropical Medicine, Kolkata.
The freshly collected plant material (stem-bark) was washed with tap water and finally with distilled water. The washed stem-bark samples were shade dried, pulverized mechanically to fine powder and stored in airtight glass containers at 4˚C for future use. All experiments were performed with same plant material within nine months from the date of collection.
Preparation of Extracts
Aqueous extract: For aqueous extraction, 20 g of air-dried, powdered plant material was added to 200 ml double distilled water (DDW) taken in a 500 ml conical flask (graduated) and boiled for 3 h. The volume of the extract was maintained to 200 ml by adding DDW time to time. It was then filtered at room temperature (RT) through cotton wool and centrifuged at 10,000 × g for 15 min. The volume of the collected supernatant was approximately 182 ml. The solution thus obtained was evaporated under reduced pressure to about 40 ml. This concentrated solution was quantitatively transferred to a 50 ml sterile volumetric flask and finally the volume was made up with sterile DDW. This solution was labeled as T.c.(a) and stored at 4˚C to use as water extract.
Methanol extract: 20 g of air dried, powdered plant material was added to 200 ml methanol taken in a 500 ml conical flask. The flask was plugged with cotton and kept on a rotary shaker at 200 -220 rpm for 24 h at RT. It was then filtered through cotton wool and centrifuged at 10,000 × g for 20 min. The supernatant was then collected and evaporated on an evaporator under reduced pressure to yield a viscous dark greenish brown mass. The above procedure was repeated for extraction in preparative scale. 200 mg of the methanol extract was dissolved in 2 ml pure DMSO (Dimethyl sulphoxide). This solution (conc n. 100 mg/ml) was labeled as T.c.(m). Ethanol extract: To prepare ethanol extract, 96% ethanol was used and rest of the procedure was as described as for the methanol extract. DMSO solution of the ethanol extract (100 mg/ml) was labelled as T.c.(e).
Fractionation/Partition of the Methanol Extract
30 g of the methanol extract was partitioned between 250 ml normal butanol (nBuOH) and 250 ml DDW. The normal butanol soluble fraction was separated and evaporated on a rotary evaporator under reduced pressure. On complete removal of the solvent, the organic part yielded dark greenish brown mass (9.8 g), 300 mg of this mass was dissolved in 3 ml of pure DMSO and the solution (100 mg/ml) was labeled as T.c.(b). On the other hand 100 ml of water soluble fraction was reduced to approximately 80 ml under vacuum. This solution (~100 mg/ml) was labeled as T.c.(w) and stored at 4˚C. 
Isolation of Triterpenoids
Biological Testing
Antimicrobial activity: The agar well diffusion assay was used to screen the antimicrobial activities of the stem bark extracts, eight isolated triterpenoids and four triterpenoid derivatives (Figure 1 ). Extracts and pure compounds were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 100 mg/ml and 2 mg/ml respectively. Figure 2 shows the antibacterial activity [17] The data reported in Figure 3 shows antibacterial activity of eight naturally occurring triterpenoids, arjunolic acid (1; 2α, 3β, 23-trihydroxyolean-12-en-28-oic acid), arjunjenin (2; 2α, 3β, 19α, 23-tetrahydroxyolean-12-en-28-oic acid), belleric acid (3; 2α, 3β, 23,24-tetrahydroxyolean-12-en-28-oic acid), terminolic Figure 3 unveils the fact that the synthetically prepared derivatives (9 -12) are somewhat more effective than naturally occurring triterpenoids.
Results
Conclusions
In vitro study with Terminalia chebula Retz. (Combretaceae) stem bark extracts, eight isolated triterpenoids and four triterpenoid derivatives were found to be effective against some common gram positive and gram negative bacteria isolated from local and patient sources. A comparative study of the efficacy of different extracts of T.chebula stem bark was also done. Major constituents of the T.chebula fruit are hydrolysable tannins and components thereof, including chebulagic acid, chebulinic acid, chebulanin, corilagin, gallic acid, gallic acid methyl ester, punicalagin, terchebulin and terminolic acid. Flavonols of interest include quercetin, isoquercitrin and rutin [23] . Fruit part of this plant was described to be used orally to treat cough with sore throat, as well as diarrhea in pharmacopoeias and well established documents [24] . In traditional medicine, fruit part was described to use orally as an anti-helminthic, astringent, cardio tonic, dentifrice, diuretic and laxative. It is also used to treat bleeding gums, diabetes, gastrointestinal disorders, ulcers and urinary disorders [25] . In WHO monographs on selected medicinal plants [23] , it was also mentioned that an aqueous extract of the fruit was active against six dermatophytes, namely Trichophyton mentagrophytes, T. rubrum, T. soudanense, Candida albicans, Torulopsis glabrata and C. krusei in vitro. The in vitro antibacterial activity of an extract of the crude drug was assessed in the disc diffusion assay. The extract was active (concentration range 30 -500 μg/disc) against human pathogenic Grampositive and Gram-negative bacteria, including Shigella dysenteriae, S. flexneri, S. boydii, Proteus mirabilis, P. vulgaris, Klebsiella pneumoniae, Pseudomonas aeruginosa and Salmonella species. A 50% ethanol extract of the fruit inhibited the growth of methicillin-resistant Staphylococcus aureus (MRSA), with a minimum inhibitory concentration of 31.3 μg/ml [26] [27] .
However the secondary metabolites of Terminalia chebula which were found to be active principle are triterpenoids in nature. Isolable quantity of these triterpenoids were very less, so it is very difficult rather impossible to use these compounds as antibacterial agents unless and until these molecules are prepared synthetically but crude extracts with those active principles could be used and/or introduced in Traditional Medicine/Complementary Alternative Medicine (TM/ CAM) as antibacterial into National Health Systems as per the guideline of Ayurvedic formularies. Synthetic approaches for further derivatization of active principles through structure-activity relationship studies may lead to development of new antibiotic(s) of higher potency.
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